Replay available

Zymeworks Inc. (ZYME) Q1 2026 Earnings Call

Zymeworks Inc. (NASDAQ: ZYME) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Thu, May 7, 2026 at 4:30 PMendedReplay
Zymeworks Inc. (ZYME) Q1 2026 Earnings Call

Hosted by

Featured presenters

Chanel Inmadar

VP of Investor Relations

Ken Galbraith

Chair and CEO

Kristen Stafford

Chief Financial Officer

Dr. Paul Moore

Preclinical Research

Dr. Sabine Mikan

SVP and Chief Medical Officer

Adam Shaywitz

Head of R&D

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Zymeworks Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.278 Good day and thank you for standing by. Welcome to ZymeWorks first quarter 2026 00:00:06.278 -- 00:00:08.921 results conference call. 00:00:08.921 -- 00:00:13.385 At this time, all participants are in the listen only mode. 00:00:13.385 -- 00:00:17.950 After the speaker's presentation, there will be a question and answer session. 00:00:17.950 -- 00:00:24.017 To ask a question during your session, you will need to press star 11 on your telephone. 00:00:24.017 -- 00:00:28.582 You will then hear an automated message advising that your hand is raised. 00:00:28.582 -- 00:00:31.609 To withdraw your question, Please press star 11 again. 00:00:31.609 -- 00:00:33.271 Please 00:00:33.271 -- 00:00:38.095 be advised that today's conference is being recorded. 00:00:38.198 -- 00:00:44.326 I would now like to hand the conference over to your first speaker today, Chanel Inmadar, 00:00:44.326 -- 00:00:49.450 VP of Investor Relations. Your line is open. 00:00:49.694 -- 00:00:54.760 Thank you, Operator. Good afternoon, everyone, and thank you for joining our first quarter 00:00:54.760 -- 00:00:58.317 2026 results conference call. 00:00:58.317 -- 00:01:02.105 As usual, I'd like to remind you that we'll be making a number of forward-looking statements 00:01:02.105 -- 00:01:06.714 during this call, including without limitation those forward-looking statements identified 00:01:06.714 -- 00:01:09.760 on our slides and the accompanying oral commentary. 00:01:09.760 -- 00:01:13.167 These forward-looking statements are based upon our current expectations and various 00:01:13.167 -- 00:01:18.365 assumptions and are subject to the risks and uncertainties including those associated 00:01:18.365 -- 00:01:22.492 with companies in our industry and at our stage of d...